Nuvation Bio Inc.
US ˙ NYSE ˙ US67080N1019

SecurityNUVB / Nuvation Bio Inc.
InstitutionCwm, Llc
Latest Disclosed Ownership106,444 shares
Latest Disclosed Value $ 456,645
Cwm, Llc reports 3.97% increase in ownership of NUVB / Nuvation Bio Inc.

On May 14, 2026 - Cwm, Llc filed a 13F-HR form disclosing ownership of 106,444 shares of Nuvation Bio Inc. (US:NUVB) valued at $456,645 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 26, 2026 disclosing 102,378 shares of Nuvation Bio Inc.. The current value of the position is $502,416 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F NUVATION BIO COM CL A 67080N101 106,444 4,066 3.97 457 0.0012
2026-01-26 2025-12-31 13F NUVATION BIO COM CL A 67080N101 102,378 50 0.05 1 0.0025
2025-10-15 2025-09-30 13F NUVATION BIO COM CL A 67080N101 102,328 64,365 169.55 0 0.0011
2025-07-25 2025-06-30 13F NUVATION BIO COM CL A 67080N101 37,963 28,387 296.44 0 0.0003
2025-05-01 2025-03-31 13F NUVATION BIO COM CL A 67080N101 9,576 -2,515 -20.80 0 0.0001
2025-02-04 2024-12-31 13F NUVATION BIO COM CL A 67080N101 12,091 6,800 128.52 0 0.0001
2024-10-08 2024-09-30 13F NUVATION BIO COM CL A 67080N101 5,291 4,197 383.64 0 0.0001
2024-07-10 2024-06-30 13F NUVATION BIO COM CL A 67080N101 1,094 1,086 13,575.00 0 0.0000
2024-04-05 2024-03-31 13F NUVATION BIO COM CL A 67080N101 8 8 0 0.0000
2023-10-11 2023-09-30 13F NUVATION BIO COM CL A 67080N101 0 -336 -100.00 0 0.0000
2023-08-03 2023-06-30 13F NUVATION BIO COM CL A 67080N101 336 336 0 0.0000
2023-02-01 2022-12-31 13F NUVATION BIO COM CL A 67080N101 0 -987 -100.00 0 -100.00
2022-10-27 2022-09-30 13F NUVATION BIO COM CL A 67080N101 987 935 1,798.08 2 0.0000
2022-07-28 2022-06-30 13F NUVATION BIO COM CL A 67080N101 52 52 0 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.